瑞舒伐他汀
普伐他汀
医学
内科学
他汀类
阿托伐他汀
优势比
辛伐他汀
雷米普利
胆固醇
血压
作者
Douglas Barthold,Geoffrey Joyce,Roberta Dı́az Brinton,Whitney Wharton,Patrick G. Kehoe,Julie Zissimopoulos
出处
期刊:PLOS ONE
[Public Library of Science]
日期:2020-03-04
卷期号:15 (3): e0229541-e0229541
被引量:55
标识
DOI:10.1371/journal.pone.0229541
摘要
Among older Americans, use of pravastatin and rosuvastatin to treat hyperlipidemia is less common than use of simvastatin and atorvastatin, however, in combination with RAS-acting AHTs, particularly ARBs, they may be more effective at reducing risk of ADRD. The number of Americans with ADRD may be reduced with drug treatments for vascular health that also confer effects on ADRD.
科研通智能强力驱动
Strongly Powered by AbleSci AI